News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Skyepharma PLC in Process of Filing Flutiform in EU
March 25, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, March 25 (Reuters) - British drug delivery specialist SkyePharma (SKP.L) said it was in the process of filing its Flutiform asthma drug for European approval, following recent setbacks in the United States.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
MORE ON THIS TOPIC
Earnings
Tariff Uncertainty Reigns Over Q1 Earnings, With Merck Taking $200M Blow So Far
April 24, 2025
·
3 min read
·
Annalee Armstrong
Vaccines
After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’
April 24, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Vanda Escalates Vendetta Against FDA, Blasts ‘Bureaucrats’ for Delaying Stomach Drug
April 24, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Guessing Game: Former HHS Workers’ Next Stops Unclear
April 24, 2025
·
5 min read
·
Angela Gabriel